Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: This phase II trial is studying how well gemcitabine and cisplatin work in treating
patients with metastatic kidney cancer.